
Enrollment in a secondary disease prevention program can have a significant impact on statin adherence and subsequent clinical outcomes.
Enrollment in a secondary disease prevention program can have a significant impact on statin adherence and subsequent clinical outcomes.
Published: October 8th 2009 | Updated:
259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831
© 2025 MJH Life Sciences®
All rights reserved.